Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Patient Perspectives - Clinical Trials Experiences through Storytelling Participants
dbrock
We are pleased to introduce three amazing clinical trial participants working with GRACE to produce educational content through storytelling!
Image
GRACE is pleased to announce the acceptance of three amazing individuals into the inaugural year of the GRACE Clinical Trials Experiences through Storytelling Program for the 2021-2022 Program Year!
We had an overwhelming response to our call for clinical trial participants who would be interested in creating educational content for others by sharing their experiences!
We are very excited to launch this new program and introduce our participants, whose backgrounds and experiences cross multiple cancer types and a variety of clinical trials. Our participants will work closely with GRACE to develop new content across a range of platforms that will help them to become established contributors, and reveal their very human experiences in impactful, educational content. We are excited to unravel these stories and to be able to help others going through similar journeys.
2021 Clinical Trials Experiences through Storytelling Program Participants
Melinda is an 11-year survivor of stage iV cholangiocarcinoma. 2 years after her diagnosis she was treated at the National Cancer Institute by Dr. Rosenberg with a clinical trial using Adoptive Cell Therapy with TIL. She shares her story in hopes of giving courage to others in need.
https://cholangiocarcinoma.org/a-clinical-trial-saved-my-life/
https://cholangiocarcinoma.com.au/melinda-bachini/
Linnea is well known in the Lung Cancer community, having just started her 6th clinical trial. In 2008 she enrolled in a successful phase 1 clinical trial. She describes her journey as both "my privilege and my burden". Her desire is to use her knowledge to help make the trial experience better by discussing what she views to be barriers to participation.
https://cancerhackerlab.com/linnea-olson/
https://www.ted.com/talks/linnea_olson_patient_parent_person_research_s…;
https://www.transceleratebiopharmainc.com/mc-resource/lung-cancer-linne…
Jared was diagnosed with non-Hodgkins lymphoma in college. In the span of nine years, Jared has had more than six recurrences and participated in four clinical trials. By sharing his story he hopes that more young adult cancer survivors will have resources available to help them.
https://www.linkedin.com/in/freelance-writer-health-cancer-pharma-healt…
Congratulations Melinda, Linnea, and Jared! We are excited to work together!
#lilly #exelixis #Novartis #Merck
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Image
Video
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.
¡Los vídeos están disponibles BAJO DEMANDA!
Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas.
Image
Article
Da click aquí para más información y para registrarte ahora
Online Community
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.